What is the study?
The main objective of the study is to analyse the immune system of long-term cancer survivors to identify if there is anything unique to the immune system of this group of individuals which is likely to contribute to their long-term survival. Can this knowledge be used to help other cancer patients?
Who’s organizing it?
The University of Surrey, funded by Continuum Life Sciences
What’s the criteria for taking part?
- No visible cancer on your scans now
- No cancer treatment for >= 5years.
- Allow us to access your medical history
- Willing to complete a lifestyle questionnaire
- Willing and able to travel to Surrey University in Guildford (when COVID safe, all expenses paid)
- Willing to donate a blood sample and a stool sample (you will be sent a stool sample kit to be done at home)
- Allow us access to your stored cancer tissue
What do I need to do?
If you think you fit the inclusion criteria for this study, please contact us on 0800 144 8488 or cltsstudy@continuumlifesciences.com
When’s the deadline?
Deadline: 30<sup>th</sup> April 2022